Stephanie Lheureux's guest appearances

Stephanie Lheureux

Research To Practice | Oncology Videos

Gynecologic Oncology Update

Ursula Matulonis

Jonathan A Ledermann

Richard T Penson

Bradley J Monk

Kathleen Moore

Michael Birrer

Alan P Venook

Zev Wainberg

Yelena Y Janjigian

Tanios Bekaii-Saab

Philip A Philip

Eileen M O’Reilly

E Gabriela Chiorean

Talia Golan

Emmanuel S Antonarakis

OwlTail

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Interview with Dr Lheureux on the following topic:  Overall survival data with maintenance olaparib for platinum-sensitive recurrent OC with germline BRCA mutation from the Phase III SOLO-2 trial; optimal integration of PARP inhibitors in the treatment of recurrent disease (00:00)  CME information and select publications

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Interview with Dr Lheureux on the following topic: <ul> <li>Overall survival data with maintenance olaparib for platinum-sensitive recurrent OC with germline BRCA mutation from the Phase III SOLO-2 trial; optimal integration of PARP inhibitors in the treatment of recurrent disease (00:00)</li> </ul> <a href="http://m.researchtopractice.com/GynOnc20/PARP/Interviews/Video" rel="nofollow" target="_blank">CME information and select publications</a>

Gynecologic Oncology | Interview with Stephanie Lheureux, MD, PhD

Joyce F Liu

A special audio supplement to an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Robert L Coleman, Stephanie Lheureux, Joyce F Liu and Kathleen Moore.

Gyn Onc 2020 PARP Interviews | Highlights from a discussion with Robert L Coleman, MD, Stephanie Lheureux, MD, PhD, Joyce F Liu, MD, MPH and Kathleen Moore, MD

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 4: Practical Considerations with the Use of PARP Inhibitors in Advanced OC — Dr Lheureux CME information and select publications

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 4: Practical Considerations with the Use of PARP Inhibitors in Advanced OC — Dr Lheureux <a href="http://m.researchtopractice.com/GynOnc20/PARP/Presentations" rel="nofollow" target="_blank">CME information and select publications</a>

Gynecologic Oncology | Stephanie Lheureux, MD, PhD